Summary & Overview
CPT 0600T: Percutaneous Irreversible Electroporation Tumor Ablation
CPT code 0600T denotes percutaneous irreversible electroporation (IRE) ablation of one or more tumors in organs other than the liver or prostate, with imaging guidance included. This code captures a minimally invasive, nonthermal tumor ablation technique that preserves surrounding connective structures and may be selected when thermal modalities are contraindicated. Its national relevance stems from the increasing adoption of image-guided, organ-preserving oncology therapies and payer scrutiny of emerging ablative technologies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines which payers recognize or adjudicate claims for this service and identifies common coding and billing considerations tied to procedure definition and site of service.
Readers will learn the clinical context for IRE ablation, billing classification for CPT code 0600T, typical sites of service, and what documentation aligns with the code definition. The report also summarizes available benchmarking and policy topics relevant to adoption and coverage decisions. Data not available in the input is noted where payer-specific coverage policies, associated taxonomies, and ICD-10 pairings are not provided.
Billing Code Overview
CPT code 0600T describes percutaneous irreversible electroporation (IRE) ablation of one or more tumors in an organ other than the liver or prostate. The procedure uses a probe inserted through the skin to deliver very short, high-voltage electrical pulses that permanently disrupt tumor cell membranes, causing cell death without thermal or cryogenic energy. Imaging guidance is included as part of the service.
-
Service type: Minimally invasive tumor ablation using irreversible electroporation
-
Typical site of service: Hospital outpatient department or ambulatory surgical center, performed percutaneously under image guidance
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient with a solitary renal cell carcinoma measuring 2.8 cm located in the mid-pole of the kidney and comorbid cardiopulmonary disease is referred for a minimally invasive ablative option. After multidisciplinary review, the interventional radiology team schedules a percutaneous irreversible electroporation (IRE) procedure using image guidance. On the day of service, the patient undergoes pre-procedure consent and time-out, moderate or general anesthesia per anesthesia team, and CT or ultrasound localization of the lesion. The provider advances one or more percutaneous probes through the skin under imaging guidance to bracket the tumor. Short, high-voltage electrical pulses are delivered to create irreversible electroporation of tumor cell membranes. Immediate post-ablation imaging is performed to assess treatment zone and detect complications. The patient is monitored in recovery and discharged same day or observed overnight depending on clinical status and institutional protocols. Follow-up imaging and oncology consultation are scheduled to evaluate treatment response and plan further therapy if needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the IRE procedure required substantially greater work than typical (unusual technical difficulty). |
23 | Unusual anesthesia | Use when general anesthesia was required for a procedure normally performed with local anesthesia, documented by anesthesia services. |
51 | Multiple procedures | Use when IRE is billed with additional separate procedures on the same day; list highest-level procedure first and append 51 to subsequent procedures per payer rules. |
52 | Reduced services | Use when the IRE procedure was partially reduced or not completed but some service was provided. |
53 | Discontinued procedure | Use when the IRE was started but terminated for reasons unrelated to patient improvement (e.g., intra-procedural complication). |
62 | Two surgeons | Use when two surgeons from different specialties jointly perform distinct portions of the IRE procedure and shared operative responsibility is documented. |
66 | Surgical team | Use when a surgical team (multiple surgeons) performs the procedure and team documentation supports billing. |
78 | Return to operating room for a related procedure by same physician | Use when the patient returns to the OR/procedure room related to complications of the initial IRE during the global period. |
80 | Assistant surgeon | Use when an assistant surgeon is present and meets payer and documentation requirements for assistant-at-surgery billing. |
81 | Minimum assistant surgeon | Use when minimal assistance is provided and payer allows reporting of a minimum assistant surgeon modifier. |
82 | Assistant surgeon (when qualified resident not available) | Use when a qualified resident would normally assist but is unavailable and a non-physician assistant performed the assistance per payer rules. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist service as a substitute for surgeon | Use when an advanced practice provider performs portions of the procedure in accordance with state scope of practice and payer rules. |
QX | Qualified nonphysician assistant | Use when a qualified nonphysician assistant at surgery is documented and eligible for reporting with this modifier. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 208800000X | Interventional Radiology | Primary specialty performing percutaneous, image-guided ablative procedures such as IRE. |
| 208600000X | Diagnostic Radiology | Radiologists experienced in image-guided percutaneous tumor ablation; may perform or assist. |
| 207P00000X | Otolaryngology (ENT) | Performs percutaneous or open ablative procedures for head and neck tumors when applicable. |
| 207L00000X | Urology | Performs percutaneous ablation for kidney or other genitourinary tumors. |
| 207K00000X | Surgical Oncology | Performs or coordinates ablative tumor treatments as part of cancer care. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
C64.1 | Malignant neoplasm of upper pole of right kidney | Renal cell carcinoma amenable to percutaneous IRE ablation. |
C64.2 | Malignant neoplasm of lower pole of right kidney | Renal tumor location treated with percutaneous IRE when surgery is high risk. |
C34.9 | Malignant neoplasm of bronchus and lung, unspecified | Small pulmonary tumors treated with percutaneous IRE when appropriate. |
C78.00 | Secondary malignant neoplasm of lung, unspecified | Metastatic lung lesions that may be targeted with percutaneous IRE for local control. |
C18.9 | Malignant neoplasm of colon, unspecified | Locoregional primary or metastatic abdominal tumors considered for IRE in select cases. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
32550 | Tube thoracostomy, includes placement of indwelling pleural catheter when performed (separate procedure) | May be performed if pneumothorax occurs as a complication of percutaneous thoracic tumor IRE or prophylactically when accessing lung lesions. |
49082 | Percutaneous ablation, kidney tumor, any method, including imaging guidance and local tumor ablation techniques (note: historically used for thermal ablation approaches) | Represents alternative percutaneous renal tumor ablation techniques; may be reported for non-IRE ablation approaches or when payer requires a different code set. |
76942 | Ultrasonic guidance for needle placement (real-time) | Reported when separate, identifiable ultrasound guidance is provided and payer allows separate reporting in addition to included imaging. |
77012 | CT guidance for placement of radiation therapy fields or interventional procedures (CT guidance for needle placement) | Used to report CT guidance for percutaneous probe placement when not included in the primary code per payer policy. |
99213 | Office/outpatient established patient visit, low to moderate complexity | Typical pre-procedure or post-procedure outpatient evaluation and management visit related to IRE planning or follow-up. |